Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Top 15 Web-based Entertainment Stages for Individual Marking - 210 Hints and Deceives to Expand Cell Phone Information Use: Capitalize on Your Information
- 3Toddler diagnosed with cancer makes remarkable recovery after aggressive treatment
- 4Watch the Geminid meteor shower peak tonight from the comfort of home with this free livestream
- 5Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- Vote in favor of your Favored sort of footwear
- Top Fascinating Organic products: Which One Might You Want to Attempt?
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- 'Zootopia 2' movie reviews: A heartwarming, hysterical and earnest 'ode to community'
- Vote in favor of the wide open action that revives your brain and soul!
- The ‘Stranger Things’ finale, explained: What happens to Vecna? And why was a key character’s fate left unknown?
- 5 Must-Attempt Fascinating Dishes from Around the World
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
- Latvia seeks emergency UN meeting over Russian missile attack on Lviv
